文献速递类风湿关节炎

抗瓜氨酸化蛋白抗体在类风湿关节炎中致病作用的当前观点

Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis.
PubMed 文献 · RMD Open · 2021-01-01

本综述总结患者来源的抗瓜氨酸化蛋白抗体(ACPA)的功能特性及其在类风湿关节炎(RA)发病中的潜在机制。ACPA阳性RA具有独特的遗传和环境风险因素,ACPA阳性健康个体在发病前即可出现关节痛和骨丢失;ACPA注射小鼠可致骨丢失和痛样行为,并在关节炎诱导剂存在下加重关节炎症。患者来源ACPA克隆具有独特细胞效应和多种靶细胞作用方式,但其高度交叉反应性使致病机制识别复杂化。

要点

  • ACPA阳性RA与阴性RA风险因素不同,ACPA阳性健康个体发病前已有骨丢失和关节痛。
  • ACPA注射小鼠致骨丢失和痛样行为,附加关节炎诱导剂时加重关节炎症。
  • 患者来源ACPA高度交叉反应,可识别氨甲酰化或乙酰化靶点,增加机制研究难度。

核心结论

  • ACPA在RA发病中具有潜在致病作用,但患者来源ACPA的高度交叉反应性使机制描述复杂化。

研究设计与样本

  • 综述汇总近期关于患者来源ACPA功能特性的数据,并提及其致病机制模型。

主要发现

  • ACPA阳性RA与独特遗传和环境风险因素相关,ACPA阳性健康个体发病前可出现关节痛和骨丢失。
  • ACPA注射小鼠可致骨丢失和痛样行为,在附加关节炎诱导剂存在下加重关节炎症。
  • 细胞实验中ACPA可结合并调节巨噬细胞、破骨细胞、滑膜成纤维细胞、中性粒细胞、肥大细胞、树突状细胞和血小板等多种靶细胞。
  • 患者来源ACPA克隆具有独特细胞效应,可通过连接关键瓜氨酸化细胞表面分子或作为免疫复合物作用于Fc受体等途径发挥作用。
  • 患者来源ACPA高度混杂和交叉反应,部分克隆还识别氨甲酰化或乙酰化靶点。

临床怎么用

  • ACPA阳性健康个体出现关节痛或骨丢失时需警惕RA发病风险。

局限性

  • 患者来源ACPA高度交叉反应且可识别多种修饰靶点,使ACPA诱导的致病机制识别和描述复杂化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidemiological findings suggest a potential role for anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) pathogenesis. ACPA-positive RA is associated with unique genetical and environmental risk factors, in contrast to seronegative RA. ACPA-positive healthy individuals are at risk of developing RA and can develop joint pain and bone loss already before disease onset. ACPA injection triggered bone loss and pain-like behaviour in mice and, in the presence of additional arthritis inducers, exacerbated joint inflammation. In cell culture experiments, ACPAs could bind to and modulate a variety of cellular targets, such as macrophages, osteoclasts, synovial fibroblasts, neutrophil granulocytes, mast cells, dendritic cells and platelets, further underlying a potential role for these autoantibodies in triggering pathogenic pathways and providing clues for their mechanisms of action. Patient-derived ACPA clones have been characterised by unique cellular effects and multiple ways to act on the target cells. ACPAs might directly induce stimulatory signals by ligating key citrullinated cell surface molecules or, alternatively, act as immune complexes on Fc receptors and potentially other molecules that recognise carbohydrate moieties. On the contrary to experimentally manufactured ACPA clones, patient-derived ACPAs are highly promiscuous and cross-reactive, suggesting a simultaneous binding to a range of functionally relevant and irrelevant targets. Moreover, several ACPA clones recognise carbamylated or acetylated targets as well. These features complicate the identification and description of ACPA-induced pathogenic mechanisms. In the current review, we summarise recent data on the functional properties of patient-derived ACPAs and present mechanistic models on how these antibodies might contribute to RA pathogenesis.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Catrina A, Krishnamurthy A, Rethi B, et al. Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis. RMD Open. 2021. PMID: 33771834. doi:10.1136/rmdopen-2020-001228

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。